Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-28 Option Award |
2023-06-29 09:00 am |
N/A 2033-06-28 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 4:45 pm |
N/A 2032-10-13 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director |
14,240 | $0 | 14,240 (Direct) |
View |
| 2022-05-06 Exercise |
2022-05-10 6:04 pm |
N/A 2028-08-17 |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner |
135,183 | $0 | 3,202,430 (Direct) |
View |
| 2022-05-06 Exercise |
2022-05-10 6:04 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner |
135,183 | $1.46 | 3,202,430 (Direct) |
View |
| 2022-05-06 Tax Withholding |
2022-05-10 6:04 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Director 10% Owner |
54,074 | $3.65 | 3,202,430 (Direct) |
View |
| 2021-07-29 Conversion |
2021-08-02 8:12 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer |
560,656 | $0 | 3,090,865 (Direct) |
View |
Ownership |
2021-07-26 9:21 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer |
0 | $0 | 3,179,787 (Direct) |
View |